GH and IGFs

Scientific Programme, ePosters & Abstracts

Previous issue | Volume 98 | ESPE2024

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

The 62nd ESPE Annual Meeting will now be taking place in Liverpool, UK.

Free Communications

Previous section
Fat, Metabolism and Obesity 1

Table of contents

Next section
Adrenals and HPA Axis 2

hrp0098fc7.1 | GH and IGFs

Clinical characteristics and response to growth hormone treatment in 27 children and adolescents with pathogenic NPR2 variants

hrp0098fc7.2 | GH and IGFs

Stratifying genetic etiology in children born small for gestational age with persistent short stature (SGA-SS): 5-year growth hormone (GH) treatment outcomes in genetic subgroups

hrp0098fc7.3 | GH and IGFs

Growth hormone (GH) deficiency and subsequent replacement therapy trigger differential expression of specific miRNAs in males and females: not just a matter of height

hrp0098fc7.4 | GH and IGFs

Growth Hormone Response to Glucagon Stimulation Test in Transitional Age

hrp0098fc7.5 | GH and IGFs

Use of overnight GH sampling in the diagnosis of growth disorders in children: neuroimaging findings and response to treatment

hrp0098fc7.6 | GH and IGFs

Growth, IGF-1 and IGFBP-3 Responses to Oral LUM-201 in OraGrowtH210 and OraGrowtH212 Trials in Pediatric Growth Hormone Deficiency (PGHD) over 12 to 24 Months on Treatment

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Abstracts